Search research articles
Contact Us
Filters
Showing results (61-70 of 182) with videos related to
Page
of 19
Sort By:
Biochemistry
|
May 11, 1982
Chiral sulfoxidations catalyzed by rat liver cytochromes P-450
D J Waxman, D R Light, C Walsh
Cancer Gene Therapy
|
September 25, 2010
Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT
J C Doloff, Y Jounaidi, D J Waxman
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels
T K Chang, H Chen, D J Waxman
Cancer Research
|
October 10, 1998
Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy
Y Jounaidi, J E Hecht, D J Waxman
The Journal of Biological Chemistry
|
December 5, 1985
The structure of phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4. Production and characterization of site-specific antibodies
A B Frey, D J Waxman, G Kreibich
Cancer Research
|
November 14, 1997
Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene
L Chen, L J Yu, D J Waxman
The Journal of Biological Chemistry
|
December 10, 1980
Linear, uncross-linked peptidoglycan secreted by penicillin-treated Bacillus subtilis. Isolation and characterization as a substrate for penicillin-sensitive D-alanine carboxypeptidases
D J Waxman, W Yu, J L Strominger
Molecular Pharmacology
|
April 18, 2001
Transcriptional induction of hepatic NADPH: cytochrome P450 oxidoreductase by thyroid hormone
H C Li, D Liu, D J Waxman
The Journal of Biological Chemistry
|
November 22, 1996
Interaction of a novel sex-dependent, growth hormone-regulated liver nuclear factor with CYP2C12 promoter
D J Waxman, S Zhao, H K Choi
Cancer Gene Therapy
|
August 5, 2000
Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model
Z Huang, M K Raychowdhury, D J Waxman
Page
of 19
Search research articles
Search
Showing results (61-70 of 182) with videos related to
Sort By:
Page
of 19
Biochemistry
|
May 11, 1982
Chiral sulfoxidations catalyzed by rat liver cytochromes P-450
D J Waxman, D R Light, C Walsh
Cancer Gene Therapy
|
September 25, 2010
Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT
J C Doloff, Y Jounaidi, D J Waxman
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels
T K Chang, H Chen, D J Waxman
Cancer Research
|
October 10, 1998
Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy
Y Jounaidi, J E Hecht, D J Waxman
The Journal of Biological Chemistry
|
December 5, 1985
The structure of phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4. Production and characterization of site-specific antibodies
A B Frey, D J Waxman, G Kreibich
Cancer Research
|
November 14, 1997
Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene
L Chen, L J Yu, D J Waxman
The Journal of Biological Chemistry
|
December 10, 1980
Linear, uncross-linked peptidoglycan secreted by penicillin-treated Bacillus subtilis. Isolation and characterization as a substrate for penicillin-sensitive D-alanine carboxypeptidases
D J Waxman, W Yu, J L Strominger
Molecular Pharmacology
|
April 18, 2001
Transcriptional induction of hepatic NADPH: cytochrome P450 oxidoreductase by thyroid hormone
H C Li, D Liu, D J Waxman
The Journal of Biological Chemistry
|
November 22, 1996
Interaction of a novel sex-dependent, growth hormone-regulated liver nuclear factor with CYP2C12 promoter
D J Waxman, S Zhao, H K Choi
Cancer Gene Therapy
|
August 5, 2000
Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model
Z Huang, M K Raychowdhury, D J Waxman
Page
of 19